(VOVWORLD) - The Vietnam Academy of Science and Technology (VAST) announced results of pre-clinical research on herbal medicine for COVID-19 called VIPDERVIR at an online press conference on Tuesday.
According to Associate Prof, Dr. Le Quang Huan, who leads the project, the main purpose of this drug is to prevent the adhesion of the virus to cells, block the ability of the virus to enter cells, inhibit the ability of viruses to multiply in cells, and activate immune cells so that they can recognize, block, and eliminate viral particles.
VIPDERVIR is made from many Vietnamese herbs containing active ingredients with valuable biopharmaceutical properties, according to Nguyen The Thinh, Head of the Traditional Medicine Management Department under the Health Ministry.
The National Ethics Committee in Biomedical Research under the Ministry of Health agreed to approve the Institute of Biotechnology’s clinical study protocol of VIPDERVIR medicine for COVID-19 patients at a meeting last Saturday.